Journal of Pharmacology and Therapeutic Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +441518081136

Rapid Communication - Journal of Pharmacology and Therapeutic Research (2023) Volume 7, Issue 2

Circulation and guideline of cyclooxygenase-2 in carrageenan-prompted irritation

Nicolas Sergeant *

Department of Pharmacology, University of Lille, Lille, France

*Corresponding Author:
Nicolas Sergeant
Department of Pharmacology
University of Lille, Lille, France

Received: 12-Feb-2023, Manuscript No. aajptr-23-91191; Editor assigned: 15-Feb-2023, PreQC No. aajptr-23-91191(PQ); Reviewed: 08-Mar-2023, QC No. aajptr-23-91191; Revised: 12-Mar-2023, Manuscript No. aajptr-23-91191(R); Published: 21-Mar-2023, DOI: 10.35841/aajptr-7.2.139

Citation: Sergeant N. Circulation and guideline of cyclooxygenase-2 in carrageenan-prompted irritation. J Pharmacol & Ther Res. 2023;7(2):139

Visit for more related articles at Journal of Pharmacology and Therapeutic Research


Prostaglandin synthases, otherwise called cyclooxygenases (COX), are proteins catalyzing the union of prostaglandin H2 from arachidonic corrosive. Prostaglandin H2 is the normal antecedent for the amalgamation of prostaglandins, prostacyclins and thromboxanes. Non-steroidal mitigating drugs (NSAIDs) are utilized as calming, hostile to pyretic and pain relieving specialists and intervene their impact through the hindrance of COX movement. Two isoforms of COX were cloned and portrayed in warm blooded animals. The COX-1 chemical is communicated in many tissues like the platelets, the kidney and the stomach. This isoform was related with a large number of the secondary effects connected with NSAIDs treatment, for example, gastro-digestive disturbance and ulceration and kidney hindrance. Conversely, the articulation example of the COX-2 quality is exceptionally confined. Nonetheless, a wide assortment of specialists like favorable to incendiary cytokines, lipopolysaccharides and development factors incite articulation of the COX-2 quality. Many reports showed that specific COX-2 inhibitors have calming and pain relieving impacts much the same way to those of customary NSAIDs yet with a significantly superior secondary effect [1].

The infusion of carrageenan to the rear paw of rodents is a typical model to concentrate on irritation and incendiary torment. Carrageenan causes aedema, an expansion in paw volume, and an exacerbated aversion to warm and mechanical upgrades which is known as hyperalgesia. Customary NSAIDs, COX-2 inhibitors and prostaglandin E2 (PGE2) monoclonal antibodies are powerful calming specialists in these models. In the paw aedema model, COX-2 levels are raised with a corresponding expansion in prostaglandin creation. Notwithstanding, a nitty gritty biochemical and histological portrayal of COX-2 enlistment in carrageenan-prompted irritation is deficient. Besides, it isn't known what NSAIDs mean for the acceptance of COX-2 in these models. The convergence of carrageenan used to test for mechanical hyperalgesia should be significantly higher than in the aedema model. In addition, carrageenan-actuated paw aedema and hyperalgesia contrast in their medication dosing routine. The paw aedema convention is a measure wherein the medication is given prophylactically before the fiery boost while hyperalgesia is an inversion examines [2].

In this paper, we examined the guideline of COX-2 in carrageenan-prompted paw aedema and hyperalgesia. We show that carrageenan builds COX-2 and PGE2 levels in the two models however this enlistment is more noteworthy and more far and wide in hyperalgesia than in aedema. We show that indomethacin blocks COX-2 enlistment in paw aedema however not in hyperalgesia recommending that a positive criticism circle directs COX-2 articulation in the paw aedema model [3].

Histological assessment of kindled paws at 3 h post-carrageenan show a complication of the connective tissues and a penetration of fiery cells in the two models. The irritation saw in the hyperalgesia model shows up more extreme than in paw aedema. Various enormous eosin-named cells, possibly macrophages and eosinophils, are seen in the free connective tissues of the excited paws. Albeit these cells are likewise present in charge paws, they were conspicuously situated between the free connective tissue and the skeletal muscle and enormous veins. Conversely, these cells were more far reaching all through the free connective tissue of the kindled paw [4].

The confinement of COX-2 immuno-reactivity (IR) demonstrates that there is a differential articulation example of COX-2 in carrageenan-advanced paw aedema when contrasted with hyperalgesia. Under basal circumstances, no COX-2 IR could be recognized. In paw aedema, COX-2 IR is seen in the layer corneum of the epidermis yet not in connective tissues or in the skeletal muscle. In hyperalgesia, COX-2 IR was not just identified in the layer corneum of the epidermis yet in addition in little penetrated cells in the connective tissues and in skeletal muscle cells. These outcomes propose that the acceptance of COX-2 is bigger and more boundless in hyperalgesia than in paw aedema [5].

Our information expands these discoveries and recommends that unmistakable and different instruments manage the outflow of COX-2. These rely upon the underlying degree of provocative improvements like the portion of carrageenan. Besides, the current concentrate on the COX-2 enlistment in carrageenan-prompted paw aedema recommends the presence of a prostanoid-subordinate positive criticism circle since this acceptance is restrained by indomethacin. This positive criticism system was likewise proposed in an ongoing model of irritation, the rodent adjuvant joint pain. In this model, remedial organization of a specific COX-2 inhibitor, SC-58125, decreased the declaration of both COX-2 mRNA and protein levels. Additional proof supporting the significance of PGE2 in this criticism circle comes from late papers depicting the enlistment of COX-2 articulation by prostaglandins in human and mouse cell [6].


  1. Anderson GD, Hauser SD, Mcgarity KL, et al. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest. 1996;97:2672-79.
  2. Indexed at, Google Scholar, Cross Ref

  3. Brideau C, Van Staden C, Styhler A, et al. The effects of phosphodiesterase type 4 inhibitors on tumor necrosis factor-a and leukotriene B4 in a novel human whole blood assay. Brit J Pharmacol. 1999;126:979-88.
  4. Indexed at, Google Scholar, Cross Ref

  5. Portanova JP, Zhang Y, Anderson GD, et al. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J Exp Med. 1996;184:883-91.
  6. Indexed at, Google Scholar, Cross Ref

  7. Riendeau D, Percival MD, Boyce S, et al. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol. 1997;121:105-17.
  8. Indexed at, Google Scholar, Cross Ref

  9. Seibert K, Zhang Y, Leahy K, et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA. 1994;91:12013-7.
  10. Indexed at, Google Scholar, Cross Ref

  11. Smith CJ, Zhang Y, Koboldt CM, et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci USA. 1998;95:13313-8.
  12. Indexed at, Google Scholar, Cross Ref

Get the App